Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ekso Bionics Holdings Inc (EKSO)

  • Technical Exchange News
  • Dec. 20, 2024, 05:44 UTC
  • 58
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 20, 2024, 05:44 UTC
  • 58
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Conduit Pharmaceuticals Inc (CDTTW)

  • Technical Exchange News
  • Dec. 20, 2024, 05:44 UTC
  • 57
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 20, 2024, 00:51 UTC
  • 53
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Altamira Therapeutics Ltd. - Common Shares. New value: Altamira Therapeutics Ltd. - Common Shares.

Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 20, 2024, 00:51 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Altamira Therapeutics Ltd. - Common Shares.

Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 20, 2024, 00:51 UTC
  • 50
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Altamira Therapeutics Ltd. - Common Shares.

Comment Full text

Senti Biosciences Inc. (SNTI)

  • Technical Exchange News
  • Dec. 19, 2024, 21:45 UTC
  • 60
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ekso Bionics Holdings Inc (EKSO)

  • Technical Exchange News
  • Dec. 19, 2024, 21:45 UTC
  • 61
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 19, 2024, 21:44 UTC
  • 62
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Conduit Pharmaceuticals Inc (CDTTW)

  • Technical Exchange News
  • Dec. 19, 2024, 21:44 UTC
  • 63
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 640
  • 641
  • 642
  • 643
  • 644
  • Next

Search

News categories

  • Technical Exchange News(14412)
  • Event(6229)
  • SEC News(376505)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(230403)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin